Cargando…
Case Report: Clinical and Serological Hallmarks of Cytokine Release Syndrome in a Canine B Cell Lymphoma Patient Treated With Autologous CAR-T Cells
BACKGROUND: Chimeric antigen receptor-T (CAR-T) cells have transformed the treatment of human B cell malignancies. With the advent of CAR-T therapy, specific and in some cases severe toxicities have been documented with cytokine release syndrome (CRS) being the most frequently reported. As dogs deve...
Autores principales: | Atherton, Matthew J., Rotolo, Antonia, Haran, Kumudhini P., Mason, Nicola J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310037/ https://www.ncbi.nlm.nih.gov/pubmed/35898541 http://dx.doi.org/10.3389/fvets.2022.824982 |
Ejemplares similares
-
Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer
por: Rotolo, Antonia, et al.
Publicado: (2021) -
Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma
por: Panjwani, M. Kazim, et al.
Publicado: (2019) -
Flow Cytometry in the Diagnosis of Canine T-Cell Lymphoma
por: Comazzi, Stefano, et al.
Publicado: (2021) -
Flow Cytometry in the Diagnosis of Canine B-Cell Lymphoma
por: Riondato, Fulvio, et al.
Publicado: (2021) -
Serological Survey of Canine Vector-Borne Infections in North-Center Spain
por: Pérez Pérez, Patricia, et al.
Publicado: (2021)